Trial Profile
Efficacy and safety of saxagliptin-initiate new stepwise triple anti-hyperglycemic therapy in drug-naive aging T2DM patients
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 May 2016
Price :
$35
*
At a glance
- Drugs Saxagliptin (Primary) ; Insulin; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 03 May 2016 New trial record